Form 4: NeueHealth Director Matthew G. Manders Reports Stock Transactions
SEC Form 4 Filing
Director Matthew G. Manders of NeueHealth, Inc. reports the acquisition and disposal of common stock and restricted stock units.
Summary
- On May 12, 2024, Matthew G. Manders, a director of NeueHealth, Inc., disposed of 6,241 shares of common stock.
- On the same day, Manders acquired 4,755 shares of common stock.
- Also on May 12, 2024, Manders acquired 4,755 restricted stock units that vested on that date.
- On May 13, 2024, Manders acquired 10,500 restricted stock units that will vest on May 13, 2025.
- Following these transactions, Manders directly owns 10,500 restricted stock units.
Sentiment
Score: 5
Explanation: This is a neutral report on stock transactions by a company director. It doesn't inherently indicate positive or negative sentiment.
Industry Context
This filing is a routine disclosure of stock transactions by a company insider, which is a common practice in publicly traded companies to ensure transparency and compliance with securities regulations.
Key Dates
| Date | Description |
|---|---|
| 05/12/2024 | Vesting of 4,755 restricted stock units and disposal of 6,241 shares of common stock. |
| 05/13/2024 | Acquisition of 10,500 restricted stock units vesting on May 13, 2025. |
| 05/13/2025 | Vesting date for 10,500 restricted stock units. |
| 05/14/2024 | Date of signature for the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.